Frankie L. Stinson

Array ( [id] => 6518546 [patent_doc_number] => 20100216970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/772749 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 14725 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216970.pdf [firstpage_image] =>[orig_patent_app_number] => 12772749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509544 [patent_doc_number] => 20100210693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/772711 [patent_app_country] => US [patent_app_date] => 2010-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9997 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210693.pdf [firstpage_image] =>[orig_patent_app_number] => 12772711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6508778 [patent_doc_number] => 20100210653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Novel Compounds, Their Preparations and Use' [patent_app_type] => utility [patent_app_number] => 12/771530 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22885 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210653.pdf [firstpage_image] =>[orig_patent_app_number] => 12771530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254727 [patent_doc_number] => 08618144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Pyrrolidine-derived beta 3 adrenergic receptor agonists' [patent_app_type] => utility [patent_app_number] => 13/319250 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14568 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543683 [patent_doc_number] => 08318975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof' [patent_app_type] => utility [patent_app_number] => 12/766178 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12265 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12766178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977987 [patent_doc_number] => 20110071144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM' [patent_app_type] => utility [patent_app_number] => 12/766106 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45524 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071144.pdf [firstpage_image] =>[orig_patent_app_number] => 12766106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536554 [patent_doc_number] => 20100204201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'HIV INTEGRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/760638 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35499 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204201.pdf [firstpage_image] =>[orig_patent_app_number] => 12760638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286277 [patent_doc_number] => 08642608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Quinazoline derivatives as VEGF inhibitors' [patent_app_type] => utility [patent_app_number] => 12/761105 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19450 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12761105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778499 [patent_doc_number] => 20120040978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Heterocyclic Fused Cinnoline M1 Receptor Positive Allosteric Modulators' [patent_app_type] => utility [patent_app_number] => 13/264267 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21535 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040978.pdf [firstpage_image] =>[orig_patent_app_number] => 13264267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141355 [patent_doc_number] => 20120095227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'COMPOUND HAVING HETERO RING SKELETON, AND PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUND USING THE AFOREMENTIONED COMPOUND AS ASYMMETRIC CATALYST' [patent_app_type] => utility [patent_app_number] => 13/259887 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14893 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095227.pdf [firstpage_image] =>[orig_patent_app_number] => 13259887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486725 [patent_doc_number] => 20100200066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF DIPYRRIN-SUBSTITUTED PORPHYRINIC MACROCYCLES' [patent_app_type] => utility [patent_app_number] => 12/756563 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18688 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20100200066.pdf [firstpage_image] =>[orig_patent_app_number] => 12756563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749542 [patent_doc_number] => 08415375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => '2-hydroxyethyl-1H-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity' [patent_app_type] => utility [patent_app_number] => 13/263922 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16614 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690186 [patent_doc_number] => 08389715 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-03-05 [patent_title] => 'Method for forming cooperative binary ionic solids' [patent_app_type] => utility [patent_app_number] => 12/756744 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3330 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760130 [patent_doc_number] => 08420651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Substituted 1-alkylcinnolin-4(1H)-one derivatives, preparation thereof and therapeutic application of same' [patent_app_type] => utility [patent_app_number] => 13/262869 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12360 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870788 [patent_doc_number] => 08466165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => '4-phenylamino-quinazolin-6-yl-amides' [patent_app_type] => utility [patent_app_number] => 12/754556 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14899 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12754556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744243 [patent_doc_number] => 20120021976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'BICYCLIC PIPERIDINE AND PIPERAZINE DERIVATIVES AS GPCR MODULATORS FOR THE TREATMENT OF OBESITY, DIABETES AND OTHER METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/260673 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21147 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021976.pdf [firstpage_image] =>[orig_patent_app_number] => 13260673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350134 [patent_doc_number] => 20100249100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS' [patent_app_type] => utility [patent_app_number] => 12/748850 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35375 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249100.pdf [firstpage_image] =>[orig_patent_app_number] => 12748850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160709 [patent_doc_number] => 20120101272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'PROCESS FOR THE PREPARATION OF ERLOTINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/258961 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6189 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101272.pdf [firstpage_image] =>[orig_patent_app_number] => 13258961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216364 [patent_doc_number] => 08629164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Inhibitors of NF-κB' [patent_app_type] => utility [patent_app_number] => 13/258512 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18958 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13258512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808033 [patent_doc_number] => 20120058987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'THERAPEUTIC USES OF QUINAZOLINEDIONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/259888 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35540 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058987.pdf [firstpage_image] =>[orig_patent_app_number] => 13259888 [rel_patent_id] =>[rel_patent_doc_number] =>)